Madrigal Pharmaceuticals
MDGL
MDGL
125 hedge funds and large institutions have $1.27B invested in Madrigal Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 46 increasing their positions, 36 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
28% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 36
15% more funds holding
Funds holding: 109 → 125 (+16)
1.08% more ownership
Funds ownership: 71.88% → 72.96% (+1.1%)
Holders
125
Holding in Top 10
2
Calls
$27.1M
Puts
$16.5M
Top Buyers
| 1 | +$14.5M | |
| 2 | +$11.9M | |
| 3 | +$11M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$6.98M |
| 5 |
Two Sigma Investments
New York
|
+$6.72M |
Top Sellers
| 1 | -$23.1M | |
| 2 | -$11M | |
| 3 | -$8.38M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.58M |
| 5 |
Jennison Associates
New York
|
-$5.36M |